Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects

Completed · Phase 4

Conditions studied: Obesity

In brief

If tigecycline clearance increases with body size then serum exposure values will be lower in obese class III compared to normal weight subjects because exposure changes inversely with clearance when the dose is fixed without regard to weight.

Key facts

Study ID
NCT01560143
Run by
Manjunath Prakash Pai
People needed
12
Starts
2012-03-01
Expected to finish
2012-05-01
Last updated by the study team
2017-02-09

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.